Takeda production site hit with suspension order over vial mix-up
This article was originally published in Scrip
Executive Summary
The prefectural government authorities of Osaka in Japan have issued a corrective order to Takeda and imposed a temporary production suspension on one of the firm's manufacturing subsidiaries, following a mix-up with an injectable product late last year.